Evidence map›Paper›PMID 30088166›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2018

Quality of life in Parkinson's disease: Italian validation of the Parkinson's Disease Questionnaire (PDQ-39-IT).

Giovanni Galeoto, Francesca Colalelli, Perla Massai, Anna Berardi, Marco Tofani, Mariangela Pierantozzi, Annamaria Servadio, Andrea Fabbrini, Giovanni Fabbrini

3 registry-linked trialsOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05902065 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Biomarkers of Rehabilitation Outcome in Patients With Parkinson's Disease: Effect of a Customized Protocol on Treadmill Training With and Without Augmented Virtual Reality Application, a Randomized Controlled Trial

TypeinterventionalSponsorUniversity of FlorenceRan2022 to 2023Enrolled60ConditionsParkinson Disease, Gait, Festinating, Fall Due to Loss of Equilibrium, Gait, UnsteadyArmsAVR Treadmill training with C-Mill, Conventional Treadmill training with C-Mill
NCT07094269 narecruitingnot on this mapstarted 2025, after this paper: background citation

Protocol for a Superiority Randomized Controlled Trial of a Group-Based Fatigue Management Program Versus Standard Information to Improve Self-Efficacy in Energy Conservation in Parkinson's Disease

TypeinterventionalSponsorUniversita degli Studi di GenovaRan2025 to 2026Enrolled80ConditionsPARKINSON DISEASE (Disorder)ArmsOccupational Therapy Intervention, Fact-sheets
NCT07384143 narecruitingnot on this mapstarted 2025, after this paper: background citation

Exploring Cognitive Recovery: the Impact of Sensor-based Robotic Rehabilitation in Neurological and Neurodegenerative Disorders

TypeinterventionalSponsorIRCCS Centro Neurolesi Bonino PulejoRan2025 to 2030Enrolled189ConditionsPARKINSON DISEASE (Disorder), Multiple Sclerosis, Stroke, Neurological DisordersArmsSensor-Based Robotic Rehabilitation with Cognitive Tasks (SBRR), Standard Conventional Therapy
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Predictor model for mild cognitive impairment in Parkinson's disease using visual rating scales.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Effects of BiodanzaJournal of personalized medicine · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Giovanni GaleotoDepartment of Public Health, Sapienza University of Rome, Rome, Italy.
Francesca Colalelli"Sapienza" University of Rome, Rome, Italy.
Perla Massai"Sapienza" University of Rome, Rome, Italy.
Anna Berardi"Sapienza" University of Rome, Rome, Italy.
Marco TofaniDepartment of Neurosciences and Neurorehabilitation, Bambino Gesù Children's Hospital, Rome, Italy.
Mariangela PierantozziDepartment of Systems Medicine, "Tor Vergata" University of Rome, Rome, Italy.
Annamaria ServadioDepartment of Health Professions, "Tor Vergata" University of Rome, Rome, Italy.
Andrea FabbriniDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università 30, 00185, Rome, Italy.
Giovanni FabbriniDepartment of Human Neurosciences, Sapienza University of Rome, Viale dell'Università 30, 00185, Rome, Italy. Giovanni.fabbrini@uniroma1.it.ORCID http://orcid.org/0000-0001-7614-8771
Sapienza University of Rome · ITUniversity of Rome Tor Vergata · ITBambino Gesù Children's Hospital · ITIstituto Neurologico Mediterraneo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translation and cross-cultural adaptation of the 39-item Parkinson's Disease Questionnaire (PDQ-39) to the Italian culture was performed by Oxford University Innovation in 2008, but this version has never been validated. Therefore, we performed the process of validation of the Italian version of the PDQ-39 (PDQ-39-IT) following the "Consensus-Based Standards for the Selection of Health Status Measurement Instruments" checklist. The translated PDQ-39-IT was tested with 104 patients diagnosed with Parkinson's disease (PD) who were recruited between June and October 2017. The mean age of the participants was 65.7 ± 10.2 years, and the mean duration of symptoms was 7.4 ± 5.3 years. The internal consistency of the PDQ-39-IT was assessed by Cronbach's alpha and ranged from 0.69 to 0.92. In an assessment of test-retest reliability in 35 of the 104 patients, the infraclass correlation coefficient (ICC) ranged from 0.85 to 0.96 for the various subitems of the PDQ-39-IT (all p < 0.01). Spearman's rank correlation coefficient for the validity of the PDQ-39-IT and the Italian version of the 36-Item Short Form (SF-36) was - 0.50 (p < 0.01). The results show that the PDQ-39-IT is a reliable and valid tool to assess the impact of PD on functioning and well-being. Thus, the PDQ-39-IT can be used in clinical and research practice to assess this construct and to evaluate the overall effect of different treatments in Italian PD patients.

Indexed as

Surveys and QuestionnairesTranslatingAdultAgedAged, 80 and overFemaleHumansItalyMaleMiddle AgedParkinson DiseaseQuality of LifeReproducibility of ResultsAssessment toolHealth-related quality of lifeHRQoLItalyParkinson’s Disease QuestionnaireReliabilityValidity

Identifiers

PMID30088166
OpenAlexW2886076751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.